Shareholder Update: Mill City Evaluating the Pharmaceutical Compounding Space
(firmenpresse) - CALGARY, ALBERTA -- (Marketwired) -- 05/01/15 -- MILL CITY GOLD CORP. ("Mill City" and/or the "Company") (TSX VENTURE: MC)(FRANKFURT: NJ6) is pleased to announce it is currently reviewing and evaluating a number of opportunities in the pharmaceutical compounding space.
Pharmaceutical compounding ("Compounding") is a branch of pharmacy that continues to play a crucial role of drug development. Compounding is the creation of a particular pharmaceutical product to fit the unique need of a patient. To do this, compounding pharmacists combine or process appropriate ingredients using various tools.
ON BEHALF OF THE BOARD OF DIRECTORS
James R. Brown, Chairman, President & CEO
The TSX Venture Exchange has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.
Contacts:
Mill City Gold Corp.
James R. Brown
403-640-0110
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 01.05.2015 - 17:39 Uhr
Sprache: Deutsch
News-ID 390239
Anzahl Zeichen: 0
contact information:
Town:
CALGARY, ALBERTA
Kategorie:
Mining & Metals
Diese Pressemitteilung wurde bisher 168 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Shareholder Update: Mill City Evaluating the Pharmaceutical Compounding Space"
steht unter der journalistisch-redaktionellen Verantwortung von
Mill City Gold Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
